Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
In 2024, cough, cold, and allergy (hay fever) remedies is expected to see a slowdown in retail current value growth in Vietnam, as the category becomes more mature. Although still seeing solid growth, consumer demand for such products has become more…
As COVID-19 restrictions have eased in Uzbekistan, the cough, cold and allergy remedy landscape was poised for a recovery. However, the introduction of restrictions and regulations for new and existing players has led to significant challenges. Due…
Cough, cold and allergy (hay fever) remedies are set to post double-digit retail value growth in 2024, benefiting from the change in the exchange rate in Argentina. Argentina’s exchange rate appreciated in the first quarter of 2024, with an immediate…
Cough, cold and allergy (hay fever) remedies is the biggest category in OTC in Ukraine with the most popular products being decongestants, pharyngeal preparations and combination products – cough, cold and allergy (hay fever) remedies. In many…
Manufacturers have raised their prices, leading to double-digit retail value growth on the landscape. Nonetheless, in many cases, consumers have continued to buy expensive branded options, having more confidence in items they are familiar with.…
Climate change is directly impacting the cough, cold and allergy (hay fever) category in Tunisia. Compared to previous decades, Tunisia is witnessing notable changes to its climate, with hotter temperatures and shorter winters taking effect. By…
Sales of cough, cold and allergy (hay fever) remedies in Thailand continue to rise strongly in 2024, due to a number of factors. As a result of industrialisation, urbanisation and greater traffic levels on the roads, there are rising levels of…
During 2024’s spring and summer months, the UK experienced another strong hay fever period as climate change prolonged the season, while increasing the potency of some pollen varieties. This supported greater consumer reliance on antihistamines and…
Cough, cold and allergy remedies is set to see a single-digit retail current value decline in the US in 2024, which is a continuation of normalisation after the extreme double-digit growth brought about by the “tripledemic” in 2022. While most…
Value sales of cough, cold and allergy (hay fever) remedies in the United Arab Emirates continue to rise. In April 2024, the United Arab Emirates experienced an unprecedented flood (in an area that rarely sees rain), which had widespread effects…
The market for cough, cold, and allergy (hay fever) remedies in the Philippines is projected to experience robust growth in current value terms in 2024. This trend is being driven by rising urbanisation, which creates favourable conditions for the…
The market for cough, cold, and allergy (hay fever) remedies in the Netherlands is expected to continue to expand in current value terms in 2024. This is being driven by increased social activity, irregular weather patterns and more frequent…
Cough, cold and allergy (hay fever) remedies in the Czech Republic is considered rather mature and driven typically by the severity of the winter and allergy seasons. The year 2023 was marked by extremely strong sales for products treating sore…
The market for cough, cold, and allergy remedies in Taiwan is expected to grow in current value terms in 2024, driven by a rise in respiratory infections, compounded by the country’s high asthma prevalence. Environmental pollution is a key factor…
The market for cough, cold, and allergy remedies in Switzerland is anticipated to continue its growth trajectory in 2024, fuelled by erratic weather patterns and a return to normal lifestyles following the pandemic. Cough remedies are expected to be…
Cough, cold and allergy (hay fever) remedies remained the largest product area within consumer health in Sweden in 2024. Consumer demand continues to normalise after the highs of the pandemic, but there are diverging results depending on the…
Cough, cold and allergy (hay fever) remedies is seeing decent, albeit declining compared to previous years, value sales in Spain in 2024. Part of this is due to the normalisation effect following the pandemic era sales spikes, and part of this is due…
Value sales of cough, cold and allergy (hay fever) remedies in South Africa continue to rise across the category in 2024, although overall demand is mainly driven by combination products, cough remedies, decongestants, medicated confectionery and…
Cough, cold and allergy (hay fever) remedies is expected to maintain strong retail current value growth in South Korea in 2024. Nevertheless, while such products are commonly used for the symptoms of rhinitis, alternative methods of treatment are…
Responsible conduct during the pandemic, such as wearing face masks, practising social distancing, and frequently washing hands, effectively limited the spread of flu-like viruses and reduced the number of people affected by commonly transmitted…